- Home
- COEP vs ORIS Comparison
COEP vs ORIS Comparison
Compare COEP & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COEP | ORIS |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 3.7M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | COEP | ORIS |
|---|---|---|
| Price | $15.25 | $1.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 94.7K | ★ 546.8K |
| Earning Date | 11-14-2025 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $500,996.00 | ★ $12,317,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $167.72 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.80 | $1.11 |
| 52 Week High | $21.41 | $45.60 |
Technical Indicators
Market Signals| Indicator | COEP | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 75.37 |
| Support Level | $13.88 | $1.11 |
| Resistance Level | $15.12 | $1.44 |
| Average True Range (ATR) | 0.78 | 0.09 |
| MACD | 0.06 | 0.12 |
| Stochastic Oscillator | 73.19 | 66.82 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).